Estimation of SARS-CoV-2 emissions from non-symptomatic cases

Introduction

The novel Coronavirus disease 2019 (COVID-19), emerged in late 2019 in Wuhan, China¹ from where it spread to the entire world. COVID-19 is caused by a novel type of Coronavirus, the severe acute respiratory syndrome virus (SARS-COV-2)². The host-receptor for SARS-CoV-2 was found to be Angiotensin I converting enzyme 2 (ACE2), which is present in cells of the lungs and airways³. A large number of patients hospitalized for other reasons and also an important proportion of the medical staff contracted COVID-19 ⁴. This is remarkable given that medical professionals are trained at protecting themselves against infections. Also a series of community-transmissions were reported from cases that had no apparent symptoms, some even without direct contact ^5–8. Correspondences about the viral load in samples from COVID-19 patients having no or only mild symptoms reported very high concentrations of SARS-CoV-2 in swab samples ^8–10. This raised the question whether transfections could occur via the air.

When coughing, humans release thousands of aerosol droplets per cubic-centimeter in the size range of 0.6 to 15 μm, with the droplet concentration increasing strongly with cough flow rate ¹¹. But also normal breathing will lead to some aerosol production, which is attributed to fluid film rupture in the respiratory bronchioles during inhalation leading to the formation of droplets that are released during exhalation ¹². The size of these droplets is mostly below 1 μm ¹³. The mode of droplet generation implies that they consist of lung lining liquid including dispersed viruses. Indeed, human volunteers exposed to virus-sized nanoparticles show nano-scaled particles in their exhaled breath ^14,15. Also, the described size distribution of particles emitted from coughing as well as normal respiration suggests that an important proportion of them will be able to remain airborne for many hours in turbulent conditions ¹⁶.

Objectives

This study aimed to estimate the cumulative viral load released from COVID-19 patients with no to moderate symptoms in different aerosol sizes via respiration and coughing. We then used this information to make a risk appraisal for the situation of a high emitter that is either breathing normally or coughing in a room operated at different air exchange rates. We chose a room size that is similar to a medical examination room or an office shared by two to three people.

Design and Methods

Model

A one-compartment model estimated the virus load concentration C for a perfectly mixed room of volume V_R of 50 m³ with one patient as source, using the following mass-balance (equation 1):

The emission rate was calculated from the concentration C_pm10, the viral load in the PM₁₀-size range, which are particles collected with a 50% efficiency cut-off at 10 μm aerodynamic diameter; and a respiratory rate of 15 breaths per minute (RR) at a tidal volume of V_t of 500 ml per breath. Air exchange rates (ER) used were 1-, 3-, 10- and 20-times per hour. The virus’ half-life t_½ of 1.1 hours was obtained from an experimental study about the persistence of SARS-CoV-2 on surfaces and when airborne ¹⁸, tested by assessing the 50% tissue culture infective dose (TCID₅₀).

The model for coughing was identical, except that coughing was assumed to happen every 30 seconds at a volume of 250 ml.

All statistics and models were calculated using Stata/SE 15.1 (Mac 64-bit Intel, Rev. 03 Feb 2020, StataCorp, College Station, TX, USA).

Results

Emissions from normal breathing patients

To estimate the virus emissions from patients breathing normally, we first calculated the viral load for the aerosol size distribution. Figure 1 shows that the highest virus load is present in the largest aerosol size. The cumulative total emission per breath was 0.34 copies/cm³(air) for an average patient, and 11.5 copies/cm³ for high emitters. The cumulative emissions in the PM₁₀ fraction were about 1/3 of these values with 0.12 copies/cm³ (average) and 4.1 copies/cm³ (high) per breath.

• Download figure
• Open in new tab

Figure 1:

Size distribution of exhaled aerosols (left) during normal respiration and resulting viral emissions per breath (right) for average (red), high and low emitters (spike-lines) per aerosol size.

Emission from coughing patient

We then estimated the virus emissions from a coughing patient (Figure 2). The cumulative total emission per cough was 19,400 copies/cm³ for an average patient, and 651,315 copies/cm³ for high emitters. The cumulative emissions in the PM₁₀ fraction were about 1/2 of these values with 10,900 copies/cm³ (average) and 366,000 copies/cm³ (high) per cough.

• Download figure
• Open in new tab

Figure 2:

Size distribution of exhaled aerosols (left) during coughing and resulting viral emissions per breath (right) with average (red), high and low emitters (spike-lines) per aerosol size.

Exposure estimation for bystanders

To estimate the exposure of bystanders spending time in the same room as a COVID-19 positive person, we calculated the time-course of the viral load in the thoracic size fraction for aerosols released from a high-emitter either breathing normally or coughing. Figure 3 shows the results for a high-emitting patient coughing frequently.

• Download figure
• Open in new tab

Figure 3:

Temporal course of airborne virus load in a perfectly mixed room of 50 m3 for different air exchange rates. The emitter has a high virus-load in the lungs and is coughing intermittently.

For a typical hospital ventilation situation of 10 air exchanges per hour, the concentration plateaus after about 30 minutes, while for a typical office with 3 air exchanges/hour, concentrations continue to rise for almost three hours. In the used model, concentrations scale linearly with the patient emission rate, the plateau concentrations for different emitting patients and ventilation types are summarized in Table 1.

View this table:

• View inline
• View popup
• Download powerpoint

Table 1: Plateau concentration for different combinations of air exchange rate, emission form and emitter type

Discussion

An elevated number of viruses is expected to be released by COIVD-19 patients in the form of airborne aerosols, especially when they are coughing. While the bigger portion of the emitted viral load is in the form of large particles that can deposit rapidly, there is also an important portion in the smaller size fractions. Small aerosols can remain airborne for an extended time ¹⁶ and are very effective at reaching the deeper regions of the lungs.

An average person breathes about a half m³ per hour in resting state ¹⁹, which can rapidly increase to several m³ during exercise ²⁰. Thus, a person spending time in a room with an average emitting patient breathing normally has a realistic chance of inhaling tens to hundreds of copies of the virus even when keeping distance from that person. The situation is worse in the presence of a high emitter and worst if the patient is a coughing high emitter. A review of a wide range of respiratory viruses suggests that the infective dose is often quite low. Sometimes as few as few hundred units of active virus (TCID₅₀) ²¹ seem sufficient to provoke a disease. Thus, our modelling suggests that there is a clear risk of infections for a person spending an extended time in the room with an infected person, even if the distance is too large for direct transmission. The situation is worse if the person is coughing.

The very high virus load in exhaled respiratory aerosols proposed by our assessment may be an explanation why COVID-19 was associated with much more transfections to hospital staff than what was expected from SARS ⁴. While having everybody wear a surgical face mask can be an effective source control ²², the protective factors may still be insufficient if an extended amount of time is spent in the same room, especially if the room is small and the ventilation low. Increasing ventilation can help to some extent but is not sufficient in a room of the size of a typical office or medical exam room. Note also that ventilation design for hospitals is complex and not always functioning as intended ²³.

What are the implications for the normal life and the workplace?

• The risk of infection is real when being near an infected person in a room for more than a few minutes and this even when keeping distance to that person.

• Sharing a workplace in a small room with a non-symptomatic case seems not advised. This implies that workplaces should not be shared as long as there are no rapid tests to differentiate between healthy and non-symptomatic cases.

• Medical staff is advised to wear the best possible respiratory protection whenever in the same room as a patient, especially when this person is coughing.

• In addition, every patient, also non-symptomatic ones, should wear a well-fitting surgical face mask to reduce emissions, which will increase the overall protection for the medical staff.

Our assessment has a number of limitations. Namely

• The estimated virus levels strongly depend on the number of virus copies produced by a COVID-19 case. We used sputum data from a well described peer-reviewed study ⁹ assuming that it is a reasonable approximation for the virus load in the respiratory bronchioles, the space where most respiratory aerosols are formed. Our high-emitter estimates would be 100-fold higher if the most extreme correspondence data was used¹⁰.

• We used information about virus copies but compare the results with TCID₅₀ infective dose. Research on other virus types suggests that the number of virus copies and TCID₅₀ are comparable ²⁴. However, it would be important to confirm this relationship for the case of SARS-CoV-2.

• For breath aerosols release, we used data reported for normal breathing young healthy subjects. However, aerosol formation is influenced by surface tension of the lung lining liquid ²⁵. It is likely that aerosol formation will be altered in COVID-19 positive cases but it is not clear in which direction.

• Aerosol droplet will shrink in dry air ²⁶, resulting in a shift to smaller particle sizes. This will not directly change the number of copies in the PM₁₀ range but simply upconcentrate the viral load per aerosol. While we addressed passivation of viruses in the air by using the documented half-life¹⁸, it is still possible that viruses in smaller droplets are quicker passivated because of shorter diffusion distances for airborne oxidants and faster increasing salinity. Our estimates would be slightly smaller if this was relevant.